Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM

Diabetes Care

Volumn 20, Issue 5, 1997, Pages 692-697

  Sundaresan, Purnima ^a   Lykos, Denise ^a   Daher, Ali ^a   Diamond, Terence ^a   Morris, Richard ^a   Howes, Laurence G ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; METFORMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030985872     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.5.692     Document Type: Article

References (14)

1. Schmidtt J, Moore J: Hypertension secondary to chlorpropamide with amelioration by changing to insulin. Am J Hypertens 6:317-319, 1993
2. Chan J, Tomlinson B, Critchley J, Cockram C, Walden R: Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care 16:1035-1038, 1993
3. Giugliano D, DeRosa N, DiMaro G, Marfella R, Acampora R, Buoninconti R, D'Onofrio F: Metformin improves glucose, lipid metabolism and reduces blood pressure in hypertensive, obese women. Diabetes Care 16:1387-1390, 1993
4. Landin K, Tengborn L, Smith U: Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 229:181-187, 1991
5. Kelly J, Pham H, Martin A, Whitworth J: Metabolic and hemodynamic effects of short term metformin administration in normotensive men (Abstract). Am J Hypertens 8:134a, 1995
6. DeFronzo R, Goodman A, Groop M: Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. N Engl J Med 333:541-549, 1995
7. McGrath B, Oliver J, Moguilevski V, Trigg L, Akama H, Shimizu K: Noradrenaline spillover to exercise muscle is increased and facilitated by angiotensin II in normal but not in heart failure rabbits (Abstract). High Blood Pressure Research Council of Australia Proceedings, Melbourne, Australia, 1995. p. 48
8. Ma A, Kamp M, Bird D, Hewlett V, Cameron DP: The effects of long term gliclazide administration on insulin secretion and insulin sensitivity. Aust N Z J Med 19:44-49, 1989
9. Anderson E, Balon T, Hoffman R, Sinkey C, Mark A: Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 19:621-627, 1992
10. Anderson E, Hoffman R, Balon T, Sinkey C, Mark A: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991
11. Sakai K, Imaizumi T, Masaki H, Takeshita A: Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 22:67-73, 1993
12. Rooney DP, Edgar JD, Sheridan B, Atkinson AB, Bell PM: The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest 21:430-435, 1991
13. Bunag RD, Krizsan-Agbas D, Itoh H: Sympathetic activation by chronic insulin treatment in conscious rats. J Pharmacol Exp Ther 259:131-138, 1991
14. Bril A, Laville M, Gout B: Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cardiovasc Res 26:1069-1076, 1992